首页> 美国卫生研究院文献>World Journal of Clinical Oncology >Current treatment options for patients with initially unresectable isolated colorectal liver metastases
【2h】

Current treatment options for patients with initially unresectable isolated colorectal liver metastases

机译:最初无法切除的孤立性结直肠肝转移患者的当前治疗选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of liver metastases is a common clinical entity in the clinical course of colorectal cancer. For patients with isolated liver involvement, surgical resection is the only treatment that can provide a chance of prolonged survival and cure. However, most of these patients are not initially eligible for the surgery. Selected patients with initially considered to have unresectable disease may become resectable after systemic (chemotherapy ± biological therapy) and loco-regional treatment modalities including hepatic arterial infusion. Patients who have colorectal liver metastases ideally should be referred to a multidisciplinary cancer care team in order to identify the most optimal management approach.
机译:肝转移的发展是大肠癌临床过程中常见的临床实体。对于孤立的肝脏受累患者,手术切除是唯一可以延长生存和治愈机会的治疗方法。但是,这些患者大多数最初都没有资格接受手术。最初被认为患有无法切除的疾病的某些患者可能会在进行全身性(化学疗法±生物疗法)和局部区域治疗方式(包括肝动脉输注)后被切除。理想情况下,患有结直肠肝转移的患者应转诊至多学科癌症护理团队,以确定最佳的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号